TipRanks
Go Ultimate55% OFF

Exponent (EP5) AI Stock Analysis

DE:EP5

Exponent

(Frankfurt:EP5)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Strong Growth and ProfitabilitySustained revenue growth alongside expanding EBITDA margins indicates strong demand and operating leverage in Exponent’s specialist services. This combination supports durable earnings growth, improves internal funding capacity, and reinforces the company’s ability to invest in talent and capabilities.
Negative Factors
Margin ModerationHistorical margin compression suggests profitability may not expand consistently with revenue, even though current margins remain strong. If this moderation persists, it could limit earnings growth, reduce operating leverage, and constrain the benefit of otherwise healthy demand.

Exponent (EP5) vs. iShares MSCI Germany ETF (EWG)

-30%-20%-10%0%10%20%30%DE:EP5+27.81%EWG+5.34%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 4.12B
Dividend Yield
1.51%
Average Volume (3M)
41
Price to Earnings (P/E)
37.3
Beta (1Y)
0.30
Revenue Growth
9.62%
EPS Growth
8.25%
Country
Germany
Employees
1,212
Sector
Industrials
Sector Strength
63
Industry
Engineering & Construction

Exponent Business Overview & Revenue Model

Company Description

Exponent, Inc. functions as a global leader in scientific and engineering consulting, operating through its subsidiaries. The firm's activities are divided into two principal segments: Engineering and Other Scientific, and Environmental and Health. T...

Exponent Earnings Call Summary

Earnings Call Date:Oct 28, 2026(Q3-2026)|% Change Since:10.57%|Next Earnings Date:Feb 03, 2027
Earnings Call SentimentPositive

The call was strongly positive. Exponent delivered double-digit revenue and earnings growth, improved EBITDA margin and utilization, raised full-year guidance, and described broad demand across user research, disputes, failure analysis, AI, data centers, transportation and chemicals. The main negatives were slower growth in Environmental and Health, the expected wind-down of a large project, higher tax and operating costs, lower interest income and no third-quarter repurchases; management nevertheless characterized demand as robust and the company as well positioned to finish 2026 strongly.

Positive Updates

Strong Third-Quarter Revenue and Earnings Growth
Third-quarter total revenues increased 18% year over year to $173.7 million, while net revenues increased 12% to $153.1 million. Net income rose 10% to $30.9 million, and diluted earnings per share increased 16% to $0.64 from $0.55.

Negative Updates

Environmental and Health Growth Lagged the Company
The Environmental and Health segment grew net revenues 3%, below the 13% growth reported by the Engineering and Other Scientific segment. Management said reacceleration depends on continued investment in senior talent, capability building and expansion into emerging chemicals and related issues.

Company Guidance

For the fourth quarter of 2026, as compared to 1 year prior, Exponent expects net revenues to grow 8% to 10% and EBITDA to be 26.3% to 26.8% of net revenues; average technical full-time equivalent employees are expected to increase approximately 4% to 5% year-over-year, utilization to be 69% to 70% as compared to 69% in the same quarter last year, and the year-over-year realized rate increase to be 3% to 3.5%; stock-based compensation is expected to be $5.7 million to $5.9 million, other operating expenses $13.5 million to $14 million, G&A expense $7.2 million to $7.7 million, interest income $700,000 to $900,000, miscellaneous income approximately $300,000, and the tax rate approximately 28% as compared to 27.4% in the same quarter a year ago. For the full year of 2026, Exponent expects net revenue growth of 10% to 11%, EBITDA to be 28% to 28.3% of net revenues as compared to 27.6% in 2025, average technical full-time equivalent employees to increase 4.7% to 5%, utilization to be 73.5% to 74% as compared to 72.5% in 2025, the year-over-year realized rate increase to be 3.7% to 4%, stock-based compensation $28.1 million to $28.4 million, other operating expenses $53 million to $53.5 million, G&A expenses $28.1 million to $28.6 million, the tax rate 28.5% as compared to 28% in 2025, and capital expenditures $10 million to $12 million; the project is expected to wind down to under 1% of revenues in the fourth quarter, and for the remainder of 2026 Exponent does not anticipate any additional tax benefit associated with share-based awards.

Exponent Risk Analysis

Exponent disclosed 35 risk factors in its most recent earnings report. Exponent reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Exponent Peers Comparison

Overall Rating

UnderperformOutperform
Sector (63)

Financial Indicators

DE:EP5 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
WLDNWLDN77Outperform$1.12B16.2920.92%―18.09%78.28%
TTEKTTEK74Outperform$9.90B23.6923.76%0.69%-7.61%105.41%
JJ64Neutral$18.10B55.839.81%0.87%20.03%-28.63%
Sector *63Neutral$10.79B15.437.44%2.01%2.89%-14.66%
BWMNBWMN62Neutral$743.62M102.122.75%―14.16%-34.06%
ACMACM48Neutral$8.15B29.7212.54%1.89%-4.24%-44.22%

* Industrials Sector Average

Performance Comparison

-40%-20%0%20%40%DE:EP5ACMJTTEKWLDNBWMNDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:EP5 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:EP5Exponent77.2014.3622.85%
ACMAecom66.25-63.80-49.06%
JJacobs Solutions Inc.159.855.503.57%
TTEKTetra Tech39.417.1021.96%
WLDNWilldan74.64-19.47-20.69%
BWMNBowman Consulting Group, Ltd.42.96-1.47-3.31%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.